Author:
Liu Li,Ye Qing,Lu Maggie,Lo Ya-Chin,Hsu Yuan-Hung,Wei Ming-Cheng,Chen Yu-Hsiang,Lo Shen-Chuan,Wang Shian-Jy,Bain Daniel J.,Ho Chien
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2015. CA: A Cancer Journal for Clinicians 65, 5–29 (2015).
2. Wheate, N. J., Walker, S., Craig, G. E. & Oun, R. The status of platinum anticancer drugs in the clinic and in clinical trials. Dalton transactions 39, 8113–8127 (2010).
3. Pabla, N. & Dong, Z. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int 73, 994–1007 (2008).
4. McWhinney, S. R., Goldberg, R. M. & McLeod, H. L. Platinum neurotoxicity pharmacogenetics. Mol Cancer Ther 8, 10–16 (2009).
5. Ulusakarya, A. et al. Acute renal failure related to oxaliplatin-induced intravascular hemolysis. Medical oncology 27, 1425–1426 (2010).
Cited by
60 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献